Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma

Oncogene

Volumn 18, Issue 4, 1999, Pages 1007-1014

  Tomizawa, Yoshio ^a,b   Kohno, Takashi ^a   Fujita, Takeshi ^c   Kiyama, Masaharu ^c   Saito, Ryusei ^b   Noguchi, Masayuki ^a   Matsuno, Yoshihiro ^a   Hirohashi, Setsuo ^a   Yamaguchi, Naohito ^a   Nakajima, Takashi ^b   Yokota, Jun ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c HITACHI LTD   (Japan)

Author keywords

p53 expression; p53 mutation; Prognosis; Stage I NSCLC

Indexed keywords

BIOLOGICAL MARKER; MUTANT PROTEIN; PROTEIN P53;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MISSENSE MUTATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ALLELES; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOMES, HUMAN, PAIR 17; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; GENES, P53; GENETIC MARKERS; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; POINT MUTATION; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033611560     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202384     Document Type: Article

References (43)

1. Bartek J, Iggo R, Gannon J and Lane DP. (1990). Oncogene, 5, 893-899.
2. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, van Tuinen P, Ledbetter DH, Baker DF, Nakamura Y, White R and Vogelstein B. (1989). Science, 244, 217-221.
3. Bodner SM, Minna JD, Jensen SM, D'Amico D, Carbone D, Mitsudomi T, Fedorko J, Buchhagen DL, Nau MM, Gazdar AF and Linnoila RI. (1992). Oncogene, 7, 743-749.
4. Borresen AL, Hovig E, Smith-Sorensen B, Malkin D, Lystad S, Andersen TI, Nesland JM, Isselbacher KJ and Friend SH. (1991). Proc. Natl. Acad. Sci. USA, 88, 8405-8409.
5. Carbone DP, Mitsudomi T, Chiba I, Piantadosi S, Rusch V, Nowak JA, McIntire D, Slamon D, Gazdar AF and Minna J. (1994). Chest, 106, 377S-381S.
6. Casey G, Lopez ME, Ramos JC, Plummer SJ, Arboleda MJ, Shaughnessy M, Karlan B and Slamon DJ. (1996). Oncogene, 13, 1971-1981.
7. Chiba I, Takahashi T, Nau MM, D'Amico D, Curiel DT, Mitsudomi T, Buchhagen DL, Carbone D, Piantadosi S, Koga H, Reissman PT, Slamon DJ, Holmes EC and Minna JD. (1990). Oncogene, 5, 1603-1610.
8. Coles C, Thompson AM, Elder PA, Cohen BB, Mackenzie IM, Cranston G, Chetty U, Mackay J, Macdonald M, Nakamura Y, Hoyheim B and Steel CM. (1990). Lancet, 336, 761-763.
9. Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Borresen AL, Cornelisse CJ and Devilee P. (1994). Cancer Res., 54, 4200-4206.
10. de Anta JM, Jassen E, Rosell R, Martinez-Roca M, Jassem J, Martinez-Lopez E, Monzo M, Sanchez-Hernandez JJ, Moreno I and Sanchez-Cespedes M. (1997). Oncogene, 15, 2951-2958.
11. Finlay CA, Hinds PW and Levine AJ. (1989). Cell, 57, 1083-1093.
12. Fong KM, Kida Y, Zimmerman PV, Ikenaga M and Smith PJ. (1995). Cancer Res., 55, 4268-4272.
13. Fukuyama Y, Mitsudomi T, Sugio K, Ishida T, Akazawa K and Sugimachi K. (1997). Br. J. Cancer, 75, 1125-1130.
14. Gannon JV, Greaves R, Iggo R and Lane DP. (1990). EMBO J., 9, 1595-1602.
15. Greenblatt MS, Bennett WP, Hollstein M and Harris C. (1994). Cancer Res., 54, 4855-4878.
16. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
17. Horio Y, Takahashi T, Kuroishi T, Hibi K, Suyama M, Niimi T, Shimokata K, Yamakawa K, Nakamura Y, Ueda R and Takahashi T. (1993). Cancer Res., 53, 1-4.
18. Iggo R, Gatter K, Bartek J, Lane D and Harris AL. (1990). Lancet, 335, 675-679.
19. Isobe T, Hiyama K, Yoshida Y, Fujiwara Y and Yamakido M. (1994). Jpn. J. Cancer Res., 85, 1240-1246.
20. Jones MH and Nakamura Y. (1992). Genes Chrom. Cancer, 5, 89-90.
21. Kiyama M and Fujita T. (1996). Biotechniques, 21, 710-716.
22. Kishimoto Y, Murakami Y, Shiraishi M, Hayashi K and Sekiya T. (1992). Cancer Res., 52, 4799-4804.
23. Lohmann D, Ruhri C, Schmitt M, Graeff H and Hofler H. (1993). Diagn. Mol. Pathol., 2, 36-41.
24. Minna JD. (1991). Harrison's Principles of Internal Medicine (edition 12). Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS and Root RK (eds). McGraw-Hill: USA, pp. 1102-1110.
25. Moore DF and Lee JS. (1996). Lung Cancer: Principles and Practice. Pass HI, Mitchell JB, Johnson DH and Turrisi AT (eds). Lippincott-Raven Publishers: Philadelphia, pp. 481-494.
26. Mitsudomi T, Oyama T, Nishida K, Ogami A, Osaki T, Nakanishi R, Sugio K, Yasumoto K and Sugimachi K. (1995). Ann. Oncol., 6, S9-S13.
27. Mitsudomi T, Oyama T, Kusano T, Osaki T, Nakanishi R and Shirakusa T. (1993). J. Natl. Cancer Inst., 85, 2018-2023.
28. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC and Vogelstein B. (1989). Nature (Lond.), 342, 705-708.
29. Ohno A, Hirashima T, Kubo A, Masuda N, Takada N, Fujiwara H, Yasumitsu T, Kikui M, Fukuoka M and Nakagawa K. (1997). Int. J. Oncol., 10, 521-528.
30. Okamoto A, Sameshima Y, Yokoyama S, Terashima Y, Sugimura T, Terada M and Yokota J. (1991a). Cancer Res., 51, 5157-5176.
31. Okamoto A, Sameshima Y, Yamada Y, Teshima S, Terashima Y, Terada M and Yokota J. (1991b). Cancer Res., 51, 5632-5636.
32. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV and Lane DP. (1990). Proc. Natl. Acad. Sci. USA, 87, 7555-7559.
33. Sakamoto T, Nomura N, Mori H and Wake N. (1996). Gynecol. Oncol., 63, 173-179.
34. Sameshima Y, Matsuno Y, Hirohashi S, Shimosato Y, Mizoguchi H, Sugimura T, Terada M and Yokota J. (1992). Oncogene, 7, 451-457.
35. Schultz DC, Vanderveer L, Berman DB, Hamilton TC, Wong AJ and Godwin AK. (1996). Cancer Res., 56, 1997-2002.
36. Shiseki M, Kohno T, Adachi J, Okazaki T, Otsuka T, Mizoguchi H, Noguchi M, Hirohashi S and Yokota J. (1996). Genes Chrom. Cancer, 17, 71-77.
37. Sommer SS, Cunningham J, McGovern RM, Saitoh S, Schroeder JJ, Wold LE and Kovach JS. (1992). J. Natl. Cancer Inst., 84, 246-252.
38. Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar AF and Minna JD. (1989). Science, 246, 491-494.
39. Thompson AM, Anderson TJ, Condie A, Prosser J, Chetty U, Carter DC, Evans HJ and Steel CM. (1992). Int. J. Cancer, 50, 528-532.
40. Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ and Baylin SB. (1995). Nat. Med., 1, 570-577.
41. WHO. (1981). Histological Typing of Lung Tumors, No. 1, Ed. 2. Geneva: WHO.
42. Yokota J and Sugimura T. (1993). FASEB J., 7, 920-925.
43. Yokota J, Wada M, Shimosato Y, Terada M and Sugimura T. (1987). Proc. Natl. Acad. Sci. USA, 84, 9252-9256.